A NEW HORIZON IN THE PATHOBIOLOGY, AETIOLOGY AND NOVEL TREATMENT OF MASTITIS IN BUFFALO

被引:0
|
作者
Dhillon, Kundan Singh [1 ]
Singh, Jasmer [1 ]
机构
[1] GADVASU, Coll Vet Sci, Ludhiana, Punjab, India
来源
BUFFALO BULLETIN | 2013年 / 32卷 / 01期
关键词
dairy buffaloes; Bubalus bubalis; mastitis; pathobiology; aetiology; BOVINE TEAT DUCT; TRISODIUM CITRATE; MILK CONSTITUENTS; PREVALENCE; CALCIUM;
D O I
暂无
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Twenty-one dairy buffaloes suffering from clinical mastitis were the subject of this investigation. The effected quarters of the animals were clinically examined. The appearanceand consistency of their milkand pH, were ascertained and recorded at the sampling site. The pH ranged from 7.00-8.50 (average 7.49). The citrate content of the milk ranged from 24.00-47.50 (average 33.71) mg /100ml. Milk from affected quarters of six buffaloes was cultured; this yielded Staphylococci from four quarters, Streptococci from one, Escherichia coli from two, Bacilli and Klebsiella from one each. On the basis of the lowered citrate content of milk in the affected quarters, the animals were treated with 12 gm or 30 gm of trisodium citrate in 250 ml of water orally once daily till recovery. With 12 gm doses daily, the recovery period was 7-13 days. However, with 30 gm daily, the recovery period was cut-short to 3-5 days. The pH (similar to 6.50) and citrate content of milk (118.30 mg/100 ml) returned to almost normal levels after treatment with trisodium citrate. The bacterial colonies also reduced significantly after the treatment. The constituents of milk, e.g., total protein, fat and lactose, increased significantly after the treatment. The results of our investigation vis-a-vis with other workers have been discussed in detail. It has been proposed logically and conceptually that the initial lesion in the udder is inflicted by the disturbed buffer system of the udder, i.e., lower levels of citrate and free Ca2++ are responsible for this injury in the udder and alkaline pH due to seepage of bicarbonate from blood into the udder providing most conducive conditions for the establishment of environmental non-contagious pathogens. Further, the treatment with trisodium citrate proved safe, economical, very effective, with no discarding of milk, no withdrawal periods and moreover no hazard from residuals in milk and meat.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 50 条
  • [41] Idiopathic granulomatous mastitis - new approach in operative treatment
    Ranisavljevic, Milan
    Solajic, Nenad
    Vicko, Ferenc
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2022, 150 (1-2) : 100 - 103
  • [42] Idiopathic granulomatous mastitis - a new approach in diagnostics and treatment
    Vanovcanova, L.
    Lehotska, V.
    Machalekova, K.
    Waczulikova, I.
    Minarikova, E.
    Rauova, K.
    Kajo, K.
    [J]. NEOPLASMA, 2019, 66 (04) : 661 - 668
  • [43] Supralevator abscess: New treatment for an uncommon aetiology: Case report
    Aparicio, David Joao
    Leichsenring, Carlos
    Sobrinho, Cisaltina
    Pignatelli, Nuno
    Geraldes, Vasco
    Nunes, Vitor
    [J]. INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 59 : 128 - 131
  • [44] A Brain Aggregate Model Gives New Insights Into the Pathobiology and Treatment of Prion Diseases
    Bajsarowicz, Krystyna
    Ahn, Misol
    Ackerman, Larry
    DeArmond, Bernadette N.
    Carlson, George
    DeArmond, Stephen J.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (05): : 449 - 466
  • [45] New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury
    Cinausero, Marika
    Aprile, Giuseppe
    Ermacora, Paola
    Basile, Debora
    Vitale, Maria G.
    Fanotto, Valentina
    Parisi, Giuseppe
    Calvetti, Lorenzo
    Sonis, Stephen T.
    [J]. FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [46] New treatment options for idiopathic pulmonary fibrosis on the horizon
    Artysh, Nataliia
    Prasse, Antje
    [J]. ZEITSCHRIFT FUR PNEUMOLOGIE, 2023, 20 (06): : 343 - 349
  • [47] GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
    Guidotti, A
    Auta, J
    Davis, JM
    Dong, EB
    Grayson, DR
    Veldic, M
    Zhang, XQ
    Costa, E
    [J]. PSYCHOPHARMACOLOGY, 2005, 180 (02) : 191 - 205
  • [48] Percutaneous treatment of tricuspid regurgitation: A new therapeutic horizon
    Vilela, Eduardo M.
    Ribeiro, Jose
    Almeida, Joao
    Fonseca, Marlene
    Dias, Adelaide
    Primo, Joao
    Braga, Pedro
    Gama, Vasco
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (03)
  • [49] A new horizon in the treatment of biofilm-associated tonsillitis
    Ciftci, Zafer
    Develioglu, Omer
    Arbak, Serap
    Ozdoganoglu, Tunis
    Gultekin, Erdogan
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2014, 8 (03) : 78 - 83
  • [50] Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
    Eun, Lucy Youngmin
    [J]. KOREAN CIRCULATION JOURNAL, 2019, 49 (02) : 192 - 193